Purchase Order 19PCRD26K1498
Award Date 12/8/25
Potential Completion Date 1/2/26
Potential Value $25K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Glaxosmithkline, LLC has been awarded a $24,928.33 firm fixed-price purchase order for medical supplies by the Bureau of Administration, a civilian federal agency. The contract was awarded on December 8, 2025, with an ultimate completion date of January 2, 2026, and will be performed in Durham, North Carolina. No set-aside designation was used for this procurement. As a foreign-owned pharmaceutical company headquartered in Durham, Glaxosmithkline specializes in delivering vaccines, antiviral...
- The U.S. Department of State's Office of the Assistant Secretary for Administration awarded a firm fixed-price delivery order valued at $451,455 to GlaxoSmithKline, LLC on April 13, 2020, with completion targeted for May 13, 2020. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not contain a set-aside designation. The work will be performed in Research Triangle Park, North Carolina, where GlaxoSmithKline maintains its primary...
- The U.S. Bureau of Administration awarded a firm fixed-price purchase order to Glaxosmithkline, LLC for medical supplies with a ceiling value of $24,928.33. The contract, which was awarded on December 8, 2025, will be performed in Durham, North Carolina, with an ultimate completion date of January 2, 2026. This procurement does not carry a set-aside designation and represents a relatively modest delivery order within Glaxosmithkline's broader federal contract portfolio. Glaxosmithkline is a...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- Glaxosmithkline, LLC was awarded a $24,000 Blanket Purchase Agreement (BPA) call for vaccines by a civilian federal agency with an ultimate completion date of December 31, 2026. The award, made on February 27, 2026, utilizes a firm fixed price contract structure with no set-aside designation. The place of performance is Durham, North Carolina, where Glaxosmithkline maintains its headquarters. This BPA call represents a delivery order against an existing blanket purchase agreement vehicle,...
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- This is a $499,100 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC. The order is for pharmaceutical goods and services under the Pandemic Influenza Preparedness and Response 2016-2021 multiple award contract. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of products to U.S. government agencies including influenza and hepatitis...
- This federal contract award is for the delivery of GLAXO VACCINES FOR STOCK to the U.S. government. The contract, valued at $164,340.40, was awarded to GlaxoSmithKline, LLC, a pharmaceutical company that specializes in vaccines, antivirals, and other pharmaceutical products. The contract is a delivery order under the General Services Administration's (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price pricing type. The contract does not have a set-aside...
- This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...
- This federal contract award is for vaccines and pharmaceutical products provided to the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration by GlaxoSmithKline, LLC. The contract has a potential value of $115,680.30, is a firm fixed price delivery order, and is not set aside for any specific business type. The contract was awarded on September 12, 2017, with a completion date of September 22, 2017. GlaxoSmithKline, a large pharmaceutical company, has...